Global Consensus on Healthcare Naming

Polycystic Ovary Syndrome renamed to Polyendocrine Metabolic Ovarian Syndrome after 14-year global process.
Renaming aims to address misleading focus on 'cysts' and improve diagnosis for 1 in 8 women.
Professor Helena Teede led effort with 56 organizations and 22,000 participants.
Lorna Berry, Australian PMOS advocate, called renaming 'accountability and progress'.
New name to be integrated into clinical practice over three years for equitable care.

Healthcare | Research | Renaming

Australia | Global | Monash University (Australia)

Professor Helena Teede | Lorna Berry

1 week ago